JP2003507356A - 血管損傷活性を有する新しいスチルベン類 - Google Patents

血管損傷活性を有する新しいスチルベン類

Info

Publication number
JP2003507356A
JP2003507356A JP2001516880A JP2001516880A JP2003507356A JP 2003507356 A JP2003507356 A JP 2003507356A JP 2001516880 A JP2001516880 A JP 2001516880A JP 2001516880 A JP2001516880 A JP 2001516880A JP 2003507356 A JP2003507356 A JP 2003507356A
Authority
JP
Japan
Prior art keywords
cis
stilbene
compounds
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001516880A
Other languages
English (en)
Japanese (ja)
Inventor
デイヴィッド デイヴィス,ピーター
Original Assignee
アンジオジーン ファーマスーティカルズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アンジオジーン ファーマスーティカルズ リミテッド filed Critical アンジオジーン ファーマスーティカルズ リミテッド
Publication of JP2003507356A publication Critical patent/JP2003507356A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/12Esters of phosphoric acids with hydroxyaryl compounds
JP2001516880A 1999-08-12 2000-08-09 血管損傷活性を有する新しいスチルベン類 Pending JP2003507356A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9918912.8A GB9918912D0 (en) 1999-08-12 1999-08-12 New stilbenes with vascular damaging activity
GB9918912.8 1999-08-12
PCT/GB2000/003067 WO2001012579A2 (en) 1999-08-12 2000-08-09 New stilbenes with vascular damaging activity

Publications (1)

Publication Number Publication Date
JP2003507356A true JP2003507356A (ja) 2003-02-25

Family

ID=10858950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001516880A Pending JP2003507356A (ja) 1999-08-12 2000-08-09 血管損傷活性を有する新しいスチルベン類

Country Status (6)

Country Link
EP (1) EP1206429A2 (it)
JP (1) JP2003507356A (it)
CA (1) CA2379544A1 (it)
GB (1) GB9918912D0 (it)
NZ (1) NZ517069A (it)
WO (1) WO2001012579A2 (it)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008506722A (ja) * 2004-07-21 2008-03-06 中国人民解放▲軍▼▲軍▼事医学科学院放射医学研究所 シス−1,2−置換スチルベン誘導体、および糖尿病の治療および/または予防のための薬剤の製造におけるそれらの使用
JP2009539779A (ja) * 2006-06-06 2009-11-19 ジョーアジアーン ダードーア ファーマスーティカル グループ カンパニー リミテッド フルオロアルコキシコンブレタスタチン誘導体とその製造方法及び用途
JP2011016777A (ja) * 2009-07-10 2011-01-27 Nipro Corp 新規システイン誘導体

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1068870B1 (en) 1998-04-03 2006-06-07 Ajinomoto Co., Inc. Antitumor agents
GB0019944D0 (en) * 2000-08-15 2000-09-27 Angiogene Pharm Ltd Compositions with vascular damaging activity
AU2002216228A1 (en) * 2000-12-21 2002-07-01 Cancer Research Ventures Limited Substituted stilbenes, their reactions and anticancer activity
FR2838437B1 (fr) 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
GB0306908D0 (en) * 2003-03-26 2003-04-30 Angiogene Pharm Ltd Bioreductively activated stilbene prodrugs
EP1631540A4 (en) * 2003-12-16 2006-10-04 Gtx Inc PRODRUGS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHOD OF USE THEREOF
PL2219451T3 (pl) 2007-11-21 2015-04-30 Oxigene Inc Sposób leczenia nowotworów tkanek krwiotwórczych
WO2012025638A1 (en) 2010-08-27 2012-03-01 Universität des Saarlandes Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors
US9353150B2 (en) 2012-12-04 2016-05-31 Massachusetts Institute Of Technology Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
AU2014228822A1 (en) 2013-03-15 2015-10-01 Memorial Sloan-Kettering Cancer Center HSP90-targeted cardiac imaging and therapy
WO2017031157A1 (en) 2015-08-18 2017-02-23 Mateon Therapeutics, Inc. Use of vdas to enhance immunomodulating therapies against tumors
WO2017197045A1 (en) 2016-05-11 2017-11-16 Movassaghi Mohammad Convergent and enantioselective total synthesis of communesin analogs
US11932650B2 (en) 2017-05-11 2024-03-19 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
WO2020092134A1 (en) 2018-10-29 2020-05-07 Cepheid Exponential base-3 nucleic acid amplification with reduced amplification time using nested overlapping primers
WO2020247054A1 (en) 2019-06-05 2020-12-10 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106177D0 (en) * 1991-03-22 1991-05-08 Aston Molecules Ltd Substituted diphenylethylenes and analogues or derivatives thereof
TW325458B (en) * 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
US5561122A (en) * 1994-12-22 1996-10-01 Arizona Board Of Regents Acting On Behalf Of Arizona State University Combretastatin A-4 prodrug
GB9903403D0 (en) * 1999-02-16 1999-04-07 Angiogene Pharm Ltd Substituted stilbene compounds with vascular damaging activity

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008506722A (ja) * 2004-07-21 2008-03-06 中国人民解放▲軍▼▲軍▼事医学科学院放射医学研究所 シス−1,2−置換スチルベン誘導体、および糖尿病の治療および/または予防のための薬剤の製造におけるそれらの使用
US8039513B2 (en) 2004-07-21 2011-10-18 Institute Of Radiation Medicine, Academy Of Military Medical Sciences, Pla Cis-1,2-substituted stilbene derivatives and their use in preparation of drugs for treatment and/or prevention of diabetes
JP2009539779A (ja) * 2006-06-06 2009-11-19 ジョーアジアーン ダードーア ファーマスーティカル グループ カンパニー リミテッド フルオロアルコキシコンブレタスタチン誘導体とその製造方法及び用途
JP2011016777A (ja) * 2009-07-10 2011-01-27 Nipro Corp 新規システイン誘導体

Also Published As

Publication number Publication date
GB9918912D0 (en) 1999-10-13
CA2379544A1 (en) 2001-02-22
EP1206429A2 (en) 2002-05-22
WO2001012579A2 (en) 2001-02-22
WO2001012579A3 (en) 2001-10-11
NZ517069A (en) 2004-04-30

Similar Documents

Publication Publication Date Title
JP2003507356A (ja) 血管損傷活性を有する新しいスチルベン類
RU2232021C2 (ru) Применение производных колхинола в качестве средств, повреждающих сосуды
EP1140078B1 (en) Benzimidazole vascular damaging agents
TWI730986B (zh) 抗真菌化合物方法
EP1896391B1 (en) Combretastatin analogs with tubulin binding activity
JP2004505888A (ja) チューブリン結合リガンドおよび対応するプロドラッグ構造
JP2002537250A (ja) 血管損傷活性での置換されたスチルベン化合物
EP1311514B1 (en) Compositions with vascular damaging activity
JP2003530433A (ja) 増殖性障害を治療するための置換スチリルベンジルスルホン
JPH07502505A (ja) 人好中球エラスターゼの阻害剤としてのフエニレンジアルカノエート類の芳香族エステル類
CA2805590C (en) Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
PT99411B (pt) Processo para a preparacao de novos carboxilatos de 2-sacarinilmetil arilo utilizados como inibidores da enzima proteolitica
JPH0559117B2 (it)
AU779980B2 (en) New stilbenes with vascular damaging activity
AU2010223209B2 (en) Tetrahydronaphthalen-2-ol derivatives
MXPA99011154A (es) Uso de derivados colquinol como agentes dañinos vasculares
MXPA99007042A (en) Quinazolinone compounds
KR20160136363A (ko) 알츠하이머 질환의 치료를 위한 6-치환된 에스트라디올 유도체
WO1999054278A1 (en) 1-(2-ALKOXY-5-CARBOXYPHENYL)-α,β-UNSATURATED KETONES, THEIR PREPARATION AND APPLICATION IN THERAPEUTICS